You are here

Large-scale study of NSAIDS finds no link to heart attack

Celebrex is less likely than naproxen and ibuprofen to cause kidney and gastrointestinal problems
Tuesday, November 15, 2016 - 05:50


IN 2004, when drugmaker Merck voluntarily pulled the pain-reliever Vioxx off the market amid evidence that it increased the risk of heart attacks, concern naturally turned to its nearly identical rival, Celebrex.

The medication works the same way, by inhibiting

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom